Anti-leukemia effects of omipalisib in acute myeloid leukemia: inhibition of PI3K/AKT/mTOR signaling and suppression of mitochondrial biogenesis.

omipalisib (GSK2126458) - GSK

dactolisib (RTB101) - Adicet Bio

gedatolisib (PF-05212384) - Celcuity

http://www.ncbi.nlm.nih.gov/pubmed/37821641

Chi-Yang Tseng; Da-Liang Ou; Hsin-An Hou; Jeng-Wei Lu; Liang-In Lin; Yu-Hsuan Fu

Oct 12, 2023